ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Olfactory Neuroblastoma (ONB) Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-17Z13118
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Olfactory Neuroblastoma ONB Market Research Report 2023
BUY CHAPTERS

Global Olfactory Neuroblastoma (ONB) Market Research Report 2025

Code: QYRE-Auto-17Z13118
Report
April 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Bristol–Myers Squibb
Merck
Pfizer Inc
Astrazeneca plc
AbbVie
Eli Lilly
Amneal Pharmaceutical
Sanofi
Cadila Pharmaceutical

Olfactory Neuroblastoma (ONB) Market Size

The global market for Olfactory Neuroblastoma (ONB) was valued at US$ 1300 million in the year 2024 and is projected to reach a revised size of US$ 2184 million by 2031, growing at a CAGR of 7.8% during the forecast period.

Olfactory Neuroblastoma (ONB) Market

Olfactory Neuroblastoma (ONB) Market

North American market for Olfactory Neuroblastoma (ONB) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Olfactory Neuroblastoma (ONB) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Olfactory Neuroblastoma (ONB) in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Olfactory Neuroblastoma (ONB) include Novartis, Bristol Myers Squibb, Merck, Pfizer, Astrazeneca, Abbvie, Eli Lilly, Amneal Pharmaceutical, Sanofi, Cadila Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Olfactory Neuroblastoma (ONB), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Olfactory Neuroblastoma (ONB).
The Olfactory Neuroblastoma (ONB) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Olfactory Neuroblastoma (ONB) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Olfactory Neuroblastoma (ONB) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Olfactory Neuroblastoma (ONB) Market Report

Report Metric Details
Report Name Olfactory Neuroblastoma (ONB) Market
Accounted market size in year US$ 1300 million
Forecasted market size in 2031 US$ 2184 million
CAGR 7.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Bristol Myers Squibb, Merck, Pfizer, Astrazeneca, Abbvie, Eli Lilly, Amneal Pharmaceutical, Sanofi, Cadila Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Olfactory Neuroblastoma (ONB) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Olfactory Neuroblastoma (ONB) Market growing?

Ans: The Olfactory Neuroblastoma (ONB) Market witnessing a CAGR of 7.8% during the forecast period 2025-2031.

What is the Olfactory Neuroblastoma (ONB) Market size in 2031?

Ans: The Olfactory Neuroblastoma (ONB) Market size in 2031 will be US$ 2184 million.

Who are the main players in the Olfactory Neuroblastoma (ONB) Market report?

Ans: The main players in the Olfactory Neuroblastoma (ONB) Market are Novartis, Bristol Myers Squibb, Merck, Pfizer, Astrazeneca, Abbvie, Eli Lilly, Amneal Pharmaceutical, Sanofi, Cadila Pharmaceutical

What are the Application segmentation covered in the Olfactory Neuroblastoma (ONB) Market report?

Ans: The Applications covered in the Olfactory Neuroblastoma (ONB) Market report are Hospital, Clinic

What are the Type segmentation covered in the Olfactory Neuroblastoma (ONB) Market report?

Ans: The Types covered in the Olfactory Neuroblastoma (ONB) Market report are Chemotherapy, Immunotherapy

Recommended Reports

Cancer Treatment Drugs

Neuro & CNS Oncology

ENT & Nasal Oncology

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.3 Market by Application
1.3.1 Global Olfactory Neuroblastoma (ONB) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Olfactory Neuroblastoma (ONB) Market Perspective (2020-2031)
2.2 Global Olfactory Neuroblastoma (ONB) Growth Trends by Region
2.2.1 Global Olfactory Neuroblastoma (ONB) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Olfactory Neuroblastoma (ONB) Historic Market Size by Region (2020-2025)
2.2.3 Olfactory Neuroblastoma (ONB) Forecasted Market Size by Region (2026-2031)
2.3 Olfactory Neuroblastoma (ONB) Market Dynamics
2.3.1 Olfactory Neuroblastoma (ONB) Industry Trends
2.3.2 Olfactory Neuroblastoma (ONB) Market Drivers
2.3.3 Olfactory Neuroblastoma (ONB) Market Challenges
2.3.4 Olfactory Neuroblastoma (ONB) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Olfactory Neuroblastoma (ONB) Players by Revenue
3.1.1 Global Top Olfactory Neuroblastoma (ONB) Players by Revenue (2020-2025)
3.1.2 Global Olfactory Neuroblastoma (ONB) Revenue Market Share by Players (2020-2025)
3.2 Global Olfactory Neuroblastoma (ONB) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Olfactory Neuroblastoma (ONB) Revenue
3.4 Global Olfactory Neuroblastoma (ONB) Market Concentration Ratio
3.4.1 Global Olfactory Neuroblastoma (ONB) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Olfactory Neuroblastoma (ONB) Revenue in 2024
3.5 Global Key Players of Olfactory Neuroblastoma (ONB) Head office and Area Served
3.6 Global Key Players of Olfactory Neuroblastoma (ONB), Product and Application
3.7 Global Key Players of Olfactory Neuroblastoma (ONB), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Olfactory Neuroblastoma (ONB) Breakdown Data by Type
4.1 Global Olfactory Neuroblastoma (ONB) Historic Market Size by Type (2020-2025)
4.2 Global Olfactory Neuroblastoma (ONB) Forecasted Market Size by Type (2026-2031)
5 Olfactory Neuroblastoma (ONB) Breakdown Data by Application
5.1 Global Olfactory Neuroblastoma (ONB) Historic Market Size by Application (2020-2025)
5.2 Global Olfactory Neuroblastoma (ONB) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Olfactory Neuroblastoma (ONB) Market Size (2020-2031)
6.2 North America Olfactory Neuroblastoma (ONB) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025)
6.4 North America Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Olfactory Neuroblastoma (ONB) Market Size (2020-2031)
7.2 Europe Olfactory Neuroblastoma (ONB) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025)
7.4 Europe Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size (2020-2031)
8.2 Asia-Pacific Olfactory Neuroblastoma (ONB) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size by Region (2020-2025)
8.4 Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Olfactory Neuroblastoma (ONB) Market Size (2020-2031)
9.2 Latin America Olfactory Neuroblastoma (ONB) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025)
9.4 Latin America Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size (2020-2031)
10.2 Middle East & Africa Olfactory Neuroblastoma (ONB) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025)
10.4 Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Olfactory Neuroblastoma (ONB) Introduction
11.1.4 Novartis Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Details
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Olfactory Neuroblastoma (ONB) Introduction
11.2.4 Bristol Myers Squibb Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Olfactory Neuroblastoma (ONB) Introduction
11.3.4 Merck Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Olfactory Neuroblastoma (ONB) Introduction
11.4.4 Pfizer Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 Astrazeneca
11.5.1 Astrazeneca Company Details
11.5.2 Astrazeneca Business Overview
11.5.3 Astrazeneca Olfactory Neuroblastoma (ONB) Introduction
11.5.4 Astrazeneca Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.5.5 Astrazeneca Recent Development
11.6 Abbvie
11.6.1 Abbvie Company Details
11.6.2 Abbvie Business Overview
11.6.3 Abbvie Olfactory Neuroblastoma (ONB) Introduction
11.6.4 Abbvie Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.6.5 Abbvie Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Olfactory Neuroblastoma (ONB) Introduction
11.7.4 Eli Lilly Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.7.5 Eli Lilly Recent Development
11.8 Amneal Pharmaceutical
11.8.1 Amneal Pharmaceutical Company Details
11.8.2 Amneal Pharmaceutical Business Overview
11.8.3 Amneal Pharmaceutical Olfactory Neuroblastoma (ONB) Introduction
11.8.4 Amneal Pharmaceutical Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.8.5 Amneal Pharmaceutical Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Olfactory Neuroblastoma (ONB) Introduction
11.9.4 Sanofi Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.9.5 Sanofi Recent Development
11.10 Cadila Pharmaceutical
11.10.1 Cadila Pharmaceutical Company Details
11.10.2 Cadila Pharmaceutical Business Overview
11.10.3 Cadila Pharmaceutical Olfactory Neuroblastoma (ONB) Introduction
11.10.4 Cadila Pharmaceutical Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.10.5 Cadila Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Novartis
Bristol–Myers Squibb
Merck
Pfizer Inc
Astrazeneca plc
AbbVie
Eli Lilly
Amneal Pharmaceutical
Sanofi
Cadila Pharmaceutical
List of Tables
 Table 1. Global Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Chemotherapy
 Table 3. Key Players of Immunotherapy
 Table 4. Global Olfactory Neuroblastoma (ONB) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Olfactory Neuroblastoma (ONB) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Olfactory Neuroblastoma (ONB) Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Olfactory Neuroblastoma (ONB) Market Share by Region (2020-2025)
 Table 8. Global Olfactory Neuroblastoma (ONB) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Olfactory Neuroblastoma (ONB) Market Share by Region (2026-2031)
 Table 10. Olfactory Neuroblastoma (ONB) Market Trends
 Table 11. Olfactory Neuroblastoma (ONB) Market Drivers
 Table 12. Olfactory Neuroblastoma (ONB) Market Challenges
 Table 13. Olfactory Neuroblastoma (ONB) Market Restraints
 Table 14. Global Olfactory Neuroblastoma (ONB) Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Olfactory Neuroblastoma (ONB) Market Share by Players (2020-2025)
 Table 16. Global Top Olfactory Neuroblastoma (ONB) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Olfactory Neuroblastoma (ONB) as of 2024)
 Table 17. Ranking of Global Top Olfactory Neuroblastoma (ONB) Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Olfactory Neuroblastoma (ONB) Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Olfactory Neuroblastoma (ONB), Headquarters and Area Served
 Table 20. Global Key Players of Olfactory Neuroblastoma (ONB), Product and Application
 Table 21. Global Key Players of Olfactory Neuroblastoma (ONB), Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Olfactory Neuroblastoma (ONB) Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Olfactory Neuroblastoma (ONB) Revenue Market Share by Type (2020-2025)
 Table 25. Global Olfactory Neuroblastoma (ONB) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Olfactory Neuroblastoma (ONB) Revenue Market Share by Type (2026-2031)
 Table 27. Global Olfactory Neuroblastoma (ONB) Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Olfactory Neuroblastoma (ONB) Revenue Market Share by Application (2020-2025)
 Table 29. Global Olfactory Neuroblastoma (ONB) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Olfactory Neuroblastoma (ONB) Revenue Market Share by Application (2026-2031)
 Table 31. North America Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Novartis Company Details
 Table 47. Novartis Business Overview
 Table 48. Novartis Olfactory Neuroblastoma (ONB) Product
 Table 49. Novartis Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
 Table 50. Novartis Recent Development
 Table 51. Bristol Myers Squibb Company Details
 Table 52. Bristol Myers Squibb Business Overview
 Table 53. Bristol Myers Squibb Olfactory Neuroblastoma (ONB) Product
 Table 54. Bristol Myers Squibb Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
 Table 55. Bristol Myers Squibb Recent Development
 Table 56. Merck Company Details
 Table 57. Merck Business Overview
 Table 58. Merck Olfactory Neuroblastoma (ONB) Product
 Table 59. Merck Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
 Table 60. Merck Recent Development
 Table 61. Pfizer Company Details
 Table 62. Pfizer Business Overview
 Table 63. Pfizer Olfactory Neuroblastoma (ONB) Product
 Table 64. Pfizer Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
 Table 65. Pfizer Recent Development
 Table 66. Astrazeneca Company Details
 Table 67. Astrazeneca Business Overview
 Table 68. Astrazeneca Olfactory Neuroblastoma (ONB) Product
 Table 69. Astrazeneca Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
 Table 70. Astrazeneca Recent Development
 Table 71. Abbvie Company Details
 Table 72. Abbvie Business Overview
 Table 73. Abbvie Olfactory Neuroblastoma (ONB) Product
 Table 74. Abbvie Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
 Table 75. Abbvie Recent Development
 Table 76. Eli Lilly Company Details
 Table 77. Eli Lilly Business Overview
 Table 78. Eli Lilly Olfactory Neuroblastoma (ONB) Product
 Table 79. Eli Lilly Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
 Table 80. Eli Lilly Recent Development
 Table 81. Amneal Pharmaceutical Company Details
 Table 82. Amneal Pharmaceutical Business Overview
 Table 83. Amneal Pharmaceutical Olfactory Neuroblastoma (ONB) Product
 Table 84. Amneal Pharmaceutical Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
 Table 85. Amneal Pharmaceutical Recent Development
 Table 86. Sanofi Company Details
 Table 87. Sanofi Business Overview
 Table 88. Sanofi Olfactory Neuroblastoma (ONB) Product
 Table 89. Sanofi Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
 Table 90. Sanofi Recent Development
 Table 91. Cadila Pharmaceutical Company Details
 Table 92. Cadila Pharmaceutical Business Overview
 Table 93. Cadila Pharmaceutical Olfactory Neuroblastoma (ONB) Product
 Table 94. Cadila Pharmaceutical Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
 Table 95. Cadila Pharmaceutical Recent Development
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources
 Table 99. Authors List of This Report


List of Figures
 Figure 1. Olfactory Neuroblastoma (ONB) Picture
 Figure 2. Global Olfactory Neuroblastoma (ONB) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Olfactory Neuroblastoma (ONB) Market Share by Type: 2024 VS 2031
 Figure 4. Chemotherapy Features
 Figure 5. Immunotherapy Features
 Figure 6. Global Olfactory Neuroblastoma (ONB) Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Olfactory Neuroblastoma (ONB) Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Clinic Case Studies
 Figure 10. Olfactory Neuroblastoma (ONB) Report Years Considered
 Figure 11. Global Olfactory Neuroblastoma (ONB) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Olfactory Neuroblastoma (ONB) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Olfactory Neuroblastoma (ONB) Market Share by Region: 2024 VS 2031
 Figure 14. Global Olfactory Neuroblastoma (ONB) Market Share by Players in 2024
 Figure 15. Global Top Olfactory Neuroblastoma (ONB) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Olfactory Neuroblastoma (ONB) as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Olfactory Neuroblastoma (ONB) Revenue in 2024
 Figure 17. North America Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Olfactory Neuroblastoma (ONB) Market Share by Country (2020-2031)
 Figure 19. United States Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Olfactory Neuroblastoma (ONB) Market Share by Country (2020-2031)
 Figure 23. Germany Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Olfactory Neuroblastoma (ONB) Market Share by Region (2020-2031)
 Figure 31. China Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Olfactory Neuroblastoma (ONB) Market Share by Country (2020-2031)
 Figure 39. Mexico Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Olfactory Neuroblastoma (ONB) Market Share by Country (2020-2031)
 Figure 43. Turkey Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Novartis Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
 Figure 47. Bristol Myers Squibb Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
 Figure 48. Merck Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
 Figure 49. Pfizer Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
 Figure 50. Astrazeneca Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
 Figure 51. Abbvie Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
 Figure 52. Eli Lilly Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
 Figure 53. Amneal Pharmaceutical Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
 Figure 54. Sanofi Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
 Figure 55. Cadila Pharmaceutical Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Neuroblastoma Treatment Drugs Market Research Report 2025
Global Neuroblastoma Drugs Market Research Report 2024
Radiation Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Retinoblastoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anosmia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Machine Olfactory Technology Market Research Report 2025
Nephroblastoma Chemotherapy Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anosmia Treatment Market Research Report 2024
Brain Tumor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oligodendroglioma Treatment Market Research Report 2024
B Cell Non Hodgkin s Lymphoma NHL Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Veterinary Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Smell and Flavor Loss Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anatomic Pathology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nitric Oxide for Inhalation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bladder Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Women s Oncology Detection Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neuroblastoma Treatment Market Insights Forecast to 2030
Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions